Digital Diabetes Management Market Driven by Growing Demand for Home Care Solutions

Market Overview:

Digital diabetes management refers to the use of digital tracking tools that monitor blood glucose and provide long-term tracking capabilities in a digital format. With steady advancement in medical device technology, tracking blood glucose levels and providing the data through digital means has become easier in the last few years. Digital diabetes management has also come into its own with the advent of mobile apps, which allow easy management of blood glucose data as well as establishing a firm link with the individual consumer and allowing the collation of data in a manner that is easily accessible for the consumer. Many leading medical device companies have entered the field of diabetes tracking apps and digital devices in the last few years, leading to steady growth of the digital diabetes management market.

The global Digital Diabetes Management Market predicted to witness striking CAGR of 23.7% during the forecast period from 2018 to 2023. This growth in the coming years is predicted on the back of increasing inclination toward the advanced health management systems coupled with large pool of diabetic people. In addition to this, the factors such as increasing demand for self-care, rising geriatric population, favorable reimbursement policies, and government initiative for raising awareness are driving growth of the global digital diabetes management market.

Competitive Analysis:

·         Ascensia Diabetes Care Holdings Ag

·         Abbott Laboratories

·         Agamatrix

·         B. Braun Melsungen AG

·         Dexcom

·         Dariohealth Corporation

·         F. Hoffmann-La Roche

·         Insulet Corporation

·         Glooko

·         Lifescan

·         Tandem Diabetes Care

·         Medtronic PLC

·         Tidepool

Segmentation:

The global digital diabetes management market is segmented on the basis of product and services, type, end user, and region.

By type, the market is segmented into wearable devices and handheld devices.

By product and Service, the market is segmented into digital diabetes management apps, data management software and platforms, and services. Of these, data management software and platforms segment is segmented into smart insulin pens, devices smart glucose meters, continuous glucose monitoring systems, smart insulin pumps/closed loop systems, and smart insulin patches. The digital diabetes management apps segment is further sub-segmented into weight & diet management apps and diabetes & blood glucose tracking apps.

By end user, the market is segmented into hospitals & specialty diabetes clinics, homecare, academic & research institutes, and others.

Regional Analysis:

The Americas are the largest digital diabetes management market, followed by Europe. Asia Pacific is expected to exhibit the fastest growth in the coming years.

Industry News:

In 2019, One Drop announced that the company is developing a diabetes management system and soon will enter into the market with advanced technology for diabetes management system which also provide accurate level of blood glucose.

In 2019, Omada Health and Blue Cross and Blue Shield of Minnesota announced the availability of Omada's Type 2 Diabetes Digital Care program. This diabetes program will be introduced for Minnesota employers in beginning January 2020.